Biocon

Biocon Revenue per Share

The Revenue per Share of Biocon (BIOCON.NS) as of Oct 18, 2026 is 113.56 INR. In the previous year, Revenue per Share was 123.45 INR — a change of -8.01% (lower).

Revenue per Share

113.56INR

YoY

-8.01%

Last updated:

Revenue per Share of Biocon is 2025 113.56 INR. Revenue per Share of Biocon was 2024 123.45 INR. It decreases by -8.01% lower compared to the previous year.

The Biocon Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2022
68.17 INR
Jan 1, 2023
93.07 INR
Jan 1, 2024
123.45 INR
Jan 1, 2025
113.56 INR
Jan 1, 2026 (e)
104.98 INR
Jan 1, 2027 (e)
119.79 INR
Jan 1, 2028 (e)
137.53 INR
Jan 1, 2029 (e)
150.80 INR
The Biocon Revenue per Share history
YEARRevenue per ShareYoY
est150.80INR+9.65%
est137.53INR+14.81%
est119.79INR+14.11%
est104.98INR-7.56%
113.56INR-8.01%
123.45INR+32.64%
93.07INR+36.54%
68.17INR+14.45%
59.56INR+13.84%
52.32INR+12.52%
46.50INR+34.37%
34.60INR+4.64%
33.07INR+16.36%
28.42INR+8.40%
26.22INR+8.99%
24.06INR+14.80%
20.96INR+19.21%
17.58INR+15.24%
15.25INR-23.60%
19.96INR+47.71%
13.52INR+53.29%
8.82INR+0.67%
8.76INR+28.93%
6.79INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biocon Stock analysis

What does Biocon do? Biocon Ltd., headquartered in Bangalore, India, operates in the Health Care sector, specializing in biotechnology. The company manufactures and develops therapeutic drugs, including generics, biosimilars, novel biologics, and research services. It employs 3,408 full-time staff and has facilities in Bangalore, Hyderabad, and Visakhapatnam. Biocon produces complex small molecule APIs such as cardiology, anti-diabetic, and oncology drugs, alongside biologics like Tacrolimus and Fingolimod, serving global markets including the US, Europe, and emerging economies. Biocon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biocon stock

Revenue per Share of Biocon is 113.56 INR in 2025.

Revenue per Share of Biocon changed from 123.45 INR to 113.56 INR, representing a -8.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Biocon since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Biocon

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Biocon